BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1015 related articles for article (PubMed ID: 30572908)

  • 21. TREM2, microglia, and Alzheimer's disease.
    Qin Q; Teng Z; Liu C; Li Q; Yin Y; Tang Y
    Mech Ageing Dev; 2021 Apr; 195():111438. PubMed ID: 33516818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model.
    Meilandt WJ; Ngu H; Gogineni A; Lalehzadeh G; Lee SH; Srinivasan K; Imperio J; Wu T; Weber M; Kruse AJ; Stark KL; Chan P; Kwong M; Modrusan Z; Friedman BA; Elstrott J; Foreman O; Easton A; Sheng M; Hansen DV
    J Neurosci; 2020 Feb; 40(9):1956-1974. PubMed ID: 31980586
    [No Abstract]   [Full Text] [Related]  

  • 23. The Pathogenesis in Alzheimer's Disease: TREM2 as a Potential Target.
    Liu G; Zhang L; Fan Y; Ji W
    J Integr Neurosci; 2023 Oct; 22(6):150. PubMed ID: 38176932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Up-regulation of TREM2 accelerates the reduction of amyloid deposits and promotes neuronal regeneration in the hippocampus of amyloid beta1-42 injected mice.
    Fan Y; Ma Y; Huang W; Cheng X; Gao N; Li G; Tian S
    J Chem Neuroanat; 2019 Apr; 97():71-79. PubMed ID: 30790627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Untangling the Role of TREM2 in Conjugation with Microglia in Neuronal Dysfunction: A Hypothesis on a Novel Pathway in the Pathophysiology of Alzheimer's Disease.
    Basha SC; Ramaiah MJ; Kosagisharaf JR
    J Alzheimers Dis; 2023; 94(s1):S319-S333. PubMed ID: 36683512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TREM2 Binds to Apolipoproteins, Including APOE and CLU/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia.
    Yeh FL; Wang Y; Tom I; Gonzalez LC; Sheng M
    Neuron; 2016 Jul; 91(2):328-40. PubMed ID: 27477018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trem2 restrains the enhancement of tau accumulation and neurodegeneration by β-amyloid pathology.
    Lee SH; Meilandt WJ; Xie L; Gandham VD; Ngu H; Barck KH; Rezzonico MG; Imperio J; Lalehzadeh G; Huntley MA; Stark KL; Foreman O; Carano RAD; Friedman BA; Sheng M; Easton A; Bohlen CJ; Hansen DV
    Neuron; 2021 Apr; 109(8):1283-1301.e6. PubMed ID: 33675684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TREM2, Microglia, and Neurodegenerative Diseases.
    Yeh FL; Hansen DV; Sheng M
    Trends Mol Med; 2017 Jun; 23(6):512-533. PubMed ID: 28442216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential interaction with TREM2 modulates microglial uptake of modified Aβ species.
    Joshi P; Riffel F; Satoh K; Enomoto M; Qamar S; Scheiblich H; Villacampa N; Kumar S; Theil S; Parhizkar S; Haass C; Heneka MT; Fraser PE; St George-Hyslop P; Walter J
    Glia; 2021 Dec; 69(12):2917-2932. PubMed ID: 34427354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TNF-α-mediated reduction in inhibitory neurotransmission precedes sporadic Alzheimer's disease pathology in young Trem2
    Ren S; Breuillaud L; Yao W; Yin T; Norris KA; Zehntner SP; D'Adamio L
    J Biol Chem; 2021; 296():100089. PubMed ID: 33434745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prior activation state shapes the microglia response to antihuman TREM2 in a mouse model of Alzheimer's disease.
    Ellwanger DC; Wang S; Brioschi S; Shao Z; Green L; Case R; Yoo D; Weishuhn D; Rathanaswami P; Bradley J; Rao S; Cha D; Luan P; Sambashivan S; Gilfillan S; Hasson SA; Foltz IN; van Lookeren Campagne M; Colonna M
    Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33446504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-Dose Ionizing Radiation Modulates Microglia Phenotypes in the Models of Alzheimer's Disease.
    Kim S; Chung H; Ngoc Mai H; Nam Y; Shin SJ; Park YH; Chung MJ; Lee JK; Rhee HY; Jahng GH; Kim Y; Lim YJ; Kong M; Moon M; Chung WK
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soluble TREM2 inhibits secondary nucleation of Aβ fibrillization and enhances cellular uptake of fibrillar Aβ.
    Belsare KD; Wu H; Mondal D; Bond A; Castillo E; Jin J; Jo H; Roush AE; Pilla KB; Sali A; Condello C; DeGrado WF
    Proc Natl Acad Sci U S A; 2022 Feb; 119(5):. PubMed ID: 35082148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TREM2 and the Progression of Alzheimer's Disease.
    Gao L; Jiang T; Yao X; Yu L; Yang X; Li Y
    Curr Neurovasc Res; 2017; 14(2):177-183. PubMed ID: 28393702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer's disease mouse models.
    Jay TR; Miller CM; Cheng PJ; Graham LC; Bemiller S; Broihier ML; Xu G; Margevicius D; Karlo JC; Sousa GL; Cotleur AC; Butovsky O; Bekris L; Staugaitis SM; Leverenz JB; Pimplikar SW; Landreth GE; Howell GR; Ransohoff RM; Lamb BT
    J Exp Med; 2015 Mar; 212(3):287-95. PubMed ID: 25732305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. APOE and TREM2 regulate amyloid-responsive microglia in Alzheimer's disease.
    Nguyen AT; Wang K; Hu G; Wang X; Miao Z; Azevedo JA; Suh E; Van Deerlin VM; Choi D; Roeder K; Li M; Lee EB
    Acta Neuropathol; 2020 Oct; 140(4):477-493. PubMed ID: 32840654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer's disease model.
    Zhong L; Xu Y; Zhuo R; Wang T; Wang K; Huang R; Wang D; Gao Y; Zhu Y; Sheng X; Chen K; Wang N; Zhu L; Can D; Marten Y; Shinohara M; Liu CC; Du D; Sun H; Wen L; Xu H; Bu G; Chen XF
    Nat Commun; 2019 Mar; 10(1):1365. PubMed ID: 30911003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of TREM2 risk variants on brain region-specific immune activation and plaque microenvironment in Alzheimer's disease patient brain samples.
    Prokop S; Miller KR; Labra SR; Pitkin RM; Hoxha K; Narasimhan S; Changolkar L; Rosenbloom A; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2019 Oct; 138(4):613-630. PubMed ID: 31350575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer's Disease.
    Griciuc A; Patel S; Federico AN; Choi SH; Innes BJ; Oram MK; Cereghetti G; McGinty D; Anselmo A; Sadreyev RI; Hickman SE; El Khoury J; Colonna M; Tanzi RE
    Neuron; 2019 Sep; 103(5):820-835.e7. PubMed ID: 31301936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TREM2 signalling as a multifaceted player in brain homoeostasis and a potential target for Alzheimer's disease treatment.
    Ayyubova G
    Eur J Neurosci; 2023 Feb; 57(4):718-733. PubMed ID: 36637116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 51.